<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 13, 2011</text>
<text top="359" left="94" width="130" height="12" font="1"> Rabbit polyclonal, USF-1 (C-20)</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="24" height="12" font="1">USF-1</text>
<text top="215" left="339" width="54" height="12" font="1"> USF-1 (C-20)</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="27" height="12" font="1">Rabbit</text>
<text top="300" left="395" width="27" height="12" font="1">A2109</text>
<text top="300" left="215" width="27" height="12" font="1">sc-229</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="43" height="12" font="2">Polyclonal</text>
<text top="413" left="94" width="408" height="12" font="1">The ubiquitously expressed cellular upstream stimulatory factor (USF) consists of USF-1 and USF-2 </text>
<text top="425" left="94" width="447" height="12" font="1">polypeptides which independently exhibit site-specific DNA binding and are members of the c-Myc-related </text>
<text top="437" left="94" width="271" height="12" font="1">family of regulatory factors containing helix-loop-helix domains.  </text>
<text top="449" left="94" width="116" height="12" font="1">Entrez gene ID 7391; 43 kDa</text>
<text top="599" left="238" width="179" height="12" font="1">http://www.scbt.com/datasheet-229-usf-1-</text>
<text top="611" left="238" width="80" height="12" font="1">c-20-antibody.html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="80" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="92" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="104" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="116" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="128" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="140" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="152" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="164" left="125" width="2" height="12" font="1"> </text>
<text top="176" left="125" width="346" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane.  </text>
<text top="188" left="125" width="2" height="12" font="1"> </text>
<text top="200" left="125" width="422" height="12" font="1">Figure legend: IP-western with sc-229 in whole cell lysate (WCL) of HeLa, HepG2, K562 and GM12878 ; </text>
<text top="212" left="125" width="196" height="12" font="1">PM=protein marker. USF1 bands are indicated. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="404" height="12" font="1">Briefly, GM12878 whole cell lysates were immunoprecipitated using primary antibody, and the IP </text>
<text top="123" left="130" width="418" height="12" font="1">fraction was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel </text>
<text top="135" left="130" width="419" height="12" font="1">was stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to </text>
<text top="147" left="130" width="397" height="12" font="1">the bands indicated above in the western blot image were excised and sent to the University of </text>
<text top="159" left="130" width="403" height="12" font="1">Alabama at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the </text>
<text top="171" left="130" width="415" height="12" font="1">samples were run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were </text>
<text top="183" left="130" width="423" height="12" font="1">identified using SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="195" left="130" width="2" height="12" font="1"> </text>
<text top="207" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="219" left="130" width="407" height="12" font="1">(ENCODE_HAIB_USF1_sc229_09122011_MassSpec.pdf), including common contaminants. Target </text>
<text top="231" left="130" width="189" height="12" font="1">protein is listed as hit 23 in the ~43 kDa band.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="11" family="Times" color="#000000"/>
	<fontspec id="4" size="10" family="Times" color="#000000"/>
<text top="72" left="77" width="282" height="16" font="3"><b>Validation 2: Mass Spectrometry Analysis </b></text>
<text top="98" left="77" width="467" height="13" font="4">ENCODE data standards recognizes various methodologies for secondary validation of </text>
<text top="112" left="77" width="467" height="13" font="4">antibodies.  Among  these  methodologies  is  immunoprecipitation  followed  by  mass </text>
<text top="126" left="77" width="467" height="13" font="4">spectrometry  analysis.  Briefly,  GM12878  whole  cell  lysates  were  immunoprecipitated </text>
<text top="140" left="77" width="467" height="13" font="4">using primary antibody, and the IP fraction was loaded on a 12% acrylamide gel and </text>
<text top="154" left="77" width="467" height="13" font="4">separated with a Bio-Rad PROTEAN II xi system. Gel was stained with Coomasie Blue </text>
<text top="167" left="77" width="467" height="13" font="4">in order to visualize marker bands. A gel fragment corresponding to the band indicated </text>
<text top="181" left="77" width="467" height="13" font="4">above in the western blot image was excised and sent to the University of Alabama at </text>
<text top="195" left="77" width="467" height="13" font="4">Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the </text>
<text top="209" left="77" width="467" height="13" font="4">sample  was  run  on  an  LTQ  XL  Linear  Ion  Trap  Mass  Spectrometer  with  alternating </text>
<text top="223" left="77" width="467" height="13" font="4">collision-induced  dissociation  and  electron-transfer  dissociation.  Peptides  were </text>
<text top="236" left="77" width="467" height="13" font="4">identified using MASCOT (Matrix Science), with probability based matching at p &lt; 0.05. </text>
<text top="250" left="77" width="467" height="13" font="4">Subsequent  analysis  was  performed  in  Scaffold  (Proteome  Software,  Inc.)  at  0.0% </text>
<text top="264" left="77" width="467" height="13" font="4">protein  FDR  and  0.0%  peptide  FDR.  As  per  ENCODE  data  standards,  all  Scaffold </text>
<text top="278" left="77" width="467" height="13" font="4">results are listed below, including common contaminants. Target protein is highlighted </text>
<text top="292" left="77" width="65" height="13" font="4">in bold font. </text>
<text top="315" left="77" width="3" height="13" font="4"> </text>
<text top="339" left="90" width="333" height="11" font="2">1.  Phosphoglycerate kinase 1 OS=Homo sapiens GN=PGK1 PE=1 SV=3 </text>
<text top="339" left="450" width="72" height="11" font="2">PGK1_HUMAN </text>
<text top="356" left="90" width="301" height="11" font="2">2.  Actin, cytoplasmic 1 OS=Homo sapiens GN=ACTB PE=1 SV=1 </text>
<text top="356" left="414" width="93" height="11" font="2">ACTB_HUMAN (+1) </text>
<text top="374" left="90" width="433" height="11" font="2">3.  Pyruvate kinase isozymes M1/M2 OS=Homo sapiens GN=PKM2 PE=1 SV=4 KPYM_HUMAN </text>
<text top="391" left="90" width="450" height="11" font="2">4.  Acetyl-CoA  acetyltransferase,  mitochondrial  OS=Homo  sapiens  GN=ACAT1  PE=1  SV=1</text>
<text top="408" left="108" width="3" height="11" font="2"> </text>
<text top="408" left="126" width="67" height="11" font="2">THIL_HUMAN </text>
<text top="425" left="90" width="343" height="11" font="2">5.  Upstream stimulatory factor 2 OS=Homo sapiens GN=USF2 PE=1 SV=1 </text>
<text top="425" left="450" width="71" height="11" font="2">USF2_HUMAN </text>
<text top="443" left="90" width="122" height="11" font="2">6.  Fructose-bisphosphate </text>
<text top="443" left="224" width="40" height="11" font="2">aldolase </text>
<text top="443" left="276" width="9" height="11" font="2">A </text>
<text top="443" left="297" width="50" height="11" font="2">OS=Homo </text>
<text top="443" left="358" width="37" height="11" font="2">sapiens </text>
<text top="443" left="407" width="58" height="11" font="2">GN=ALDOA </text>
<text top="443" left="476" width="28" height="11" font="2">PE=1 </text>
<text top="443" left="515" width="25" height="11" font="2">SV=2</text>
<text top="460" left="108" width="3" height="11" font="2"> </text>
<text top="460" left="126" width="79" height="11" font="2">ALDOA_HUMAN </text>
<text top="477" left="90" width="395" height="11" font="2">7.  Actin-related protein 2 OS=Homo sapiens GN=ACTR2 PE=1 SV=1  ARP2_HUMAN </text>
<text top="494" left="90" width="343" height="11" font="2">8.  Elongation factor 1-alpha 1 OS=Homo sapiens GN=EEF1A1 PE=1 SV=1 </text>
<text top="494" left="450" width="76" height="11" font="2">EF1A1_HUMAN </text>
<text top="512" left="90" width="361" height="11" font="2">9.  Alpha-enolase OS=Homo sapiens GN=ENO1 PE=1 SV=2  ENOA_HUMAN </text>
<text top="529" left="90" width="450" height="11" font="2">10.  Developmentally-regulated  GTP-binding  protein  1  OS=Homo  sapiens  GN=DRG1  PE=1  SV=1</text>
<text top="546" left="108" width="3" height="11" font="2"> </text>
<text top="546" left="126" width="73" height="11" font="2">DRG1_HUMAN </text>
<text top="563" left="90" width="453" height="11" font="2">11.  Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial OS=Homo sapiens GN=IDH3B PE=1 </text>
<text top="581" left="108" width="28" height="11" font="2">SV=2 </text>
<text top="581" left="162" width="74" height="11" font="2">IDH3B_HUMAN </text>
<text top="598" left="90" width="453" height="11" font="2">12.  Medium-chain specific acyl-CoA dehydrogenase, mitochondrial OS=Homo sapiens GN=ACADM </text>
<text top="615" left="108" width="135" height="11" font="2">PE=1 SV=1 ACADM_HUMAN </text>
<text top="632" left="90" width="122" height="11" font="2">13.  Fructose-bisphosphate </text>
<text top="632" left="224" width="40" height="11" font="2">aldolase </text>
<text top="632" left="275" width="10" height="11" font="2">C </text>
<text top="632" left="297" width="50" height="11" font="2">OS=Homo </text>
<text top="632" left="358" width="37" height="11" font="2">sapiens </text>
<text top="632" left="407" width="58" height="11" font="2">GN=ALDOC </text>
<text top="632" left="476" width="28" height="11" font="2">PE=1 </text>
<text top="632" left="515" width="25" height="11" font="2">SV=2</text>
<text top="650" left="108" width="3" height="11" font="2"> </text>
<text top="650" left="126" width="79" height="11" font="2">ALDOC_HUMAN </text>
<text top="667" left="90" width="450" height="11" font="2">14.  ATP  synthase  subunit  beta,  mitochondrial  OS=Homo  sapiens  GN=ATP5B  PE=1  SV=3</text>
<text top="684" left="108" width="3" height="11" font="2"> </text>
<text top="684" left="126" width="71" height="11" font="2">ATPB_HUMAN </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="5" size="7" family="Times" color="#000000"/>
<text top="72" left="90" width="450" height="11" font="2">15.  26S  protease  regulatory  subunit  10B  OS=Homo  sapiens  GN=PSMC6  PE=1  SV=1</text>
<text top="90" left="108" width="3" height="11" font="2"> </text>
<text top="90" left="126" width="77" height="11" font="2">PRS10_HUMAN </text>
<text top="107" left="90" width="327" height="11" font="2">16.  40S ribosomal protein SA OS=Homo sapiens GN=RPSA PE=1 SV=4 </text>
<text top="107" left="450" width="72" height="11" font="2">RSSA_HUMAN </text>
<text top="124" left="90" width="453" height="11" font="2">17.  HLA  class  I  histocompatibility  antigen,  Cw-4  alpha  chain  OS=Homo  sapiens  GN=HLA-C  PE=1 </text>
<text top="141" left="108" width="28" height="11" font="2">SV=1 </text>
<text top="141" left="162" width="90" height="11" font="2">1C04_HUMAN (+2) </text>
<text top="159" left="90" width="450" height="11" font="2">18.  Heterogeneous  nuclear  ribonucleoprotein  D0  OS=Homo  sapiens  GN=HNRNPD  PE=1  SV=1</text>
<text top="176" left="108" width="3" height="11" font="2"> </text>
<text top="176" left="126" width="81" height="11" font="2">HNRPD_HUMAN </text>
<text top="193" left="90" width="450" height="11" font="2">19.  Heat  shock  protein  HSP  90-beta  OS=Homo  sapiens  GN=HSP90AB1  PE=1  SV=4</text>
<text top="210" left="108" width="3" height="11" font="2"> </text>
<text top="210" left="126" width="77" height="11" font="2">HS90B_HUMAN </text>
<text top="228" left="90" width="453" height="11" font="2">20.  Isocitrate  dehydrogenase  [NAD]  subunit  alpha,  mitochondrial  OS=Homo  sapiens  GN=IDH3A </text>
<text top="245" left="108" width="128" height="11" font="2">PE=1 SV=1 IDH3A_HUMAN </text>
<text top="262" left="90" width="401" height="11" font="2">21.  Stomatin-like protein 2 OS=Homo sapiens GN=STOML2 PE=1 SV=1 STML2_HUMAN </text>
<text top="279" left="90" width="295" height="11" font="2">22.  Tubulin beta chain OS=Homo sapiens GN=TUBB PE=1 SV=2 </text>
<text top="279" left="414" width="70" height="11" font="2">TBB5_HUMAN </text>
<text top="297" left="90" width="431" height="11" font="5"><b>23.  Upstream stimulatory factor 1 OS=Homo sapiens GN=USF1 PE=1 SV=1  USF1_HUMAN </b></text>
<text top="323" left="90" width="3" height="14" font="4">	 Â </text>
</page>
</pdf2xml>
